Genetic polymorphisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean women

British Journal of Cancer

Volumn 88, Issue 5, 2003, Pages 675-678

  Lee, K M ^a   Abel, J ^b   Ko, Y ^c   Harth, V ^c   Park, W Y ^a   Seo, J S ^a   Yoo, K Y ^a   Choi, J Y ^a   Shin, A ^a   Ahn, S H ^d   Noh, D Y ^a   Hirvonen, A ^e   Kang, D ^a  

^a Seoul National University College of Medicine   (South Korea)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d University of Ulsan College of Medicine   (South Korea)

^e FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

Alcohol; Breast cancer; CYP19; CYP1B1

Indexed keywords

ALCOHOL; ARGININE; AROMATASE; CYSTEINE; CYTOCHROME P450 1B1; CYTOCHROME P450 ISOENZYME; LEUCINE; UNCLASSIFIED DRUG; VALINE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BREAST CARCINOMA; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; KOREA; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PRIORITY JOURNAL;

ADULT; AGED; ALCOHOL DRINKING; AROMATASE; ARYL HYDROCARBON HYDROXYLASES; BASE SEQUENCE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; HUMANS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0037430056     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600761     Document Type: Article

References (22)

1. Bailey LR, Roodi N, Dupont WD, Parl FF (1998) Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res 58: 5038-5041
2. Baxter SW, Choong DYH, Eccles DM, Campbell IG (2001) Polymorphic variation in CYP19 and the risk of breast cancer. Carcinogenesis 22: 347-349
3. Brüning T, Abel J, Koch B, Lorenzen K, Harth V, Donat S, Sachinidis A, Vetter H, Bolt HM, Ko BY (1999) Real-time PCR-analysis of the cytochrome P450 1B1 codon 432-polymorphism. Arch Toxicol 73: 427-430
4. Dorgan JF, Baer DJ, Albert PS, Judd JT, Brown ED, Corle DK, Campbell WS, Hartman TJ, Clevidence BA, Giffen CA, Chandler DW, Stanczyk FZ, Taylor PR (2001) Serum hormones and the alcohol-breast cancer association in postmenopausal women. J Natl Cancer Inst 93: 710-715
5. Haiman CA, Hankinson SE, Siegelmann D, Vivo IE, Golditz GA, Willett WC, Speizer FE, Hunter DJ (2000) A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk. Int J Cancer 87: 204-210
6. Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ, Sutter TR (1996) 17b-Estradiol hydroxylation catalyzed by human cytochrome P4501B1. Proc Natl Acad Sci 93: 9776-9781
7. Healey CS, Dunning AM, Durocher F, Teare D, Pharoah PDP, Luben RN, Easton DF, Ponder BAJ (2000) Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk. Carcinogenesis 21: 189-193
8. Ko Y, Abel J, Harth V, Bröde P, Antony C, Donat S, Fischer HP, Oritiz-Pallardo ME, Thier R, Sachinidis A, Vetter H, Bolt HM, Herberhold C, Brüning T (2001) Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. Cancer Res 61: 4398-4404
9. Kristensen VN, Andersen TI, Lindlom A, Erikstein B, Magnus P, Börrensen-Dale A (1998) A rare CYP19 (aromatase) variant may increase the risk of breast cancer. Pharmacogenetics 8: 43-48
10. Miyoshi Y, Iwao K, Ikeda N, Egawa C, Noguchi S (2000) Breast cancer risk associated with polymorphism in CYP19 in Japanese women. Int J Cancer 89: 325-328
11. Park SK, Yoo KY, Lee SJ, Kim SU, Ahn SH, Nob DY, Choe KJ, Stricland PT, Hirvonen A, Kang D (2000) Alcohol consumption, glutathlone S-transferase M1 and T1 genetic polymorphisms and breast cancer risk. Pharmacognetics 10: 301-309
12. Polymeropulous MH, Xiao H, Rath DS, Merri CR (1991) Tetranucleotide repeat polymorphism at the human aromatase cytochrome P-450 gene (CYP19). Nucleic Acids Res 19: 195
13. Siegelmann-Danieli N, Buetow KH (1999) Constitutional genetic variation at the human aromatase gene (CYP19) and breast cancer risk. Br J Cancer 79: 456-463
14. Singletary KW, Gapstur SM (2001) Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. J Am Med Assoc 286: 2143-2151
15. Sourdaine P, Parker MG, Telford J, Miller WR (1994) Analysis of the aromatase cytochrome P450 gene in human breast tumors. J Mol Endocrinol 13: 331-337
16. Thompsen PA, Ambrosone C (2000) Chapter 7: molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. J Natl Cancer Inst Monogr 27: 125-134
17. Watanabe J, Harada N, Suemasu K, Higashi Y, Gotoh O, Kawajiri K (1997) Arginine-cystein polymorphism at codon 264 of the human CYP19 gene does not affect aromatase activity. Pharmacogenetics 7: 419-424
18. Watanabe J, Shimada T, Gillam EMJ, Ikuta I, Suemasu K, Higashi Y, Gotoh O, Kawajiri K (2000) Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics 10: 25-33
19. Yager JD (2000) Chapter 3: endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr 27: 67-73
20. 158Met polymorphism of catechol O-methyl transferase and breast cancer. Pharmacogenetics 11: 279-286
21. Yoo KY, Park SK, Sung JH, Kang DH, Kim YC, Kang HS, Sub JS, Kim JS, Yun IJ, Han SH, Noh DY, Choe KJ (1998) High risk groups for female breast cancer in Korea. J Korean Cancer Assoc 30: 435-439
22. Zheng W, Xie DW, Jin F, Cheng JR, Dai Q, Wen WQ, Shu XO, Gao YT (2000) Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer. Cancer Epidemiol Biomark Prev 9: 147-150